¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"crude natural increase rate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • natural resistance
    ÀÚ¿¬ÀúÇ×
  • natural selection
    ÀÚ¿¬µµÅÂ
  • natural sleep
    ÀÚ¿¬¼ö¸é
  • natural antibody
    ÀÚ¿¬Ç×ü
  • natural birth
    ÀÚ¿¬ºÐ¸¸
  • natural childbirth
    ÀÚ¿¬ºÐ¸¸
  • natural death
    ÀÚ¿¬»ç
  • natural emerging method
    ÀÚ¿¬À¯Ãâ¹ý
  • natural experiment
    ÀÚ¿¬½ÇÇè
  • natural immunity
    ÀÚ¿¬¸é¿ª
  • natural infection
    ÀÚ¿¬°¨¿°
  • natural killer cell
    ÀÚ¿¬»ìÇØ¼¼Æ÷
  • arterial perfusion rate
    µ¿¸Æ°ü·ùÀ²
  • attack rate
    ¹ßº´·ü
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • fatality rate
    Ä¡¸í·ü
  • fertility rate
    »ý½Ä·ü, ¼öÅÂÀ²
  • fetal death rate
    žƻç¸Á·ü
  • fetal heart rate
    žƽɹڼö
  • five-year survival rate
    ¿À³â»ýÁ¸·ü
  • glomerular filtration rate
    Å丮¿©°úÀ², »ç±¸Ã¼¿©°úÀ²
  • heart rate
    ½ÉÀå¹Úµ¿¼ö
  • infant mortality rate
    ¿µ¾Æ»ç¸Á·ü
  • morbidity rate
    ÀÌȯ·ü
  • mortality rate
    »ç¸Á·ü
  • mutation rate
    µ¹¿¬º¯ÀÌÀ²
  • onset rate
    ¹ß»ý·ü
  • operative mortality rate
    ¼ö¼ú»ç¸Á·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • natural death
    ÀÚ¿¬»ç
  • natural enemy
    ̵˞
  • natural experiment
    ÀÚ¿¬½ÇÇè
  • natural gypsum
    õ¿¬¼®°í
  • natural history
    ÀÚ¿¬°æ°ú
  • natural host
    ÀÚ¿¬¼÷ÁÖ
  • natural immunity
    ÀÚ¿¬¸é¿ª
  • natural infection
    ÀÚ¿¬°¨¿°
  • natural mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
  • natural abrasive material
    õ¿¬¿¬»èÀç·á
  • natural emerging method
    ÀÚ¿¬À¯Ãâ¹ý
  • natural parthenogenesis
    ÀÚ¿¬Ã³³à»ý½Ä
  • natural population
    ÀÚ¿¬Áý´Ü, ÀÚ¿¬°³Ã¼±º
  • natural radiation
    ÀÚ¿¬¹æ»ç¼±
  • natural radioactivity
    ÀÚ¿¬¹æ»ç´É, õ¿¬¹æ»ç´É
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âºñ(¡­üµÑ¨Ýï)
  • arterial perfusion rate
    µ¿¸Æ°ü·ùÀ²
  • fractional fibrinogen catabolic rate
    ºÐȹº° ¼¶À¯¼Ò¿ø ´ë»çÀ².
  • frame rate
    È­¸éÀ²
  • frame rate
    È­¸é ¹ß»ýÀ² (ûþØü Û¡ßæëÒ)
  • general fertility rate
    ÀϹÝÃâ»êÀ².
  • general fertility rate
    ÀϹÝÃâ»êÀ².
  • glomerular filtration rate
    »ç±¸Ã¼ ¿©°úÀ²
  • glomerular filtration rate
    »ç±¸Ã¼¿©°úÀ²
  • glomerular filtration rate =GFR
    »ç±¸Ã¼¿©°úÀ²(¡­ÕëΦëÏ).
  • glomerular filtration rate =GFR
    »ç±¸Ã¼¿©°úÀ².
  • gross reproduction rate
    ÃÑÀç»ý»êÀ².
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • crude petroleum
    ¿øÀ¯.
  • crude rubber
    »ý°í¹«.
  • crude tubercle
    °Ç¶ô¼º °áÇÙ(ËòÕ©àõÌ¿ú·).
  • crude urine
    Èñ¹Ú´¢(ýüÚÝèñ).
  • galenical preparation =crude drugs
    »ý¾à (ßæå·).
  • mixed base crude oil
    È¥ÇÕ±â¿øÀ¯(ûèùêÐñ ê«êú).
  • antibody, natural
    ÀÚ¿¬Ç×ü
  • cell, natural killer
    ÀÚ¿¬»ìÇØ¼¼Æ÷, NK¼¼Æ÷
  • congenital amputation =natural a., spont an eus a.
    ¼±Ãµ¼º Àý´Ü(à»ô¸àõôîÓ¨), ÀÚ¿¬ Àý´Ü(í»æÔôîÓ¨).
  • infection, natural
    ÀÚ¿¬°¨¿°
  • liquefied natural gas
    ¾×ȭõ¿¬(äûûùô¸æÔ)°¡½º.
  • natural abortion
    ÀÚ¿¬À¯»ê(í»æÔêüß§).
  • natural abrasive material
    õ¿¬¿¬»èÀç·á(ô¸æÔæÚÞûî§è÷).
  • natural antibody
    ÀÚ¿¬Ç×ü(í»æÔù÷ô÷).
  • natural antibody
    ÀÚ¿¬Ç×ü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rate zonal centrifugation
    ¼Óµµ ±¸¿ª ¿ø½ÉºÐ¸®(áÜÓøÏ¡æ´êÀãýÝÂ×î)
  • mutation rate
    º¯ÀÌÀ²(ܨì¶ëÒ)
  • reaction rate
    ¹ÝÀÀ ¼Óµµ·Ð(ÚãëëáÜÓøÖå)
  • specific growth rate
    ºñ¼ºÀåÀ²(Ýïà÷íþëÒ)
  • specific rate constant
    ƯÀÌ ¼Óµµ»ó¼ö(÷åì¶áÜÓøßÈâ¦)
  • specific reaction rate
    ƯÀÌ ¹ÝÀÀ¼Óµµ(÷åì¶ÚãëëáÜÓø)
  • transfer rate coefficient
    ÀüÀÌ ¼Óµµ °è¼ö(ï®ì¹áÜÓøÌõâ¦)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CBR carbonyl reductase; chemical, biological, and radiological [warfare]; chemically-bound residue; chro...
CMR cardiomodulorespirography; cerebral metabolic rate; chief medical resident; common medical record; c...
ACR abnormally contracting region; absolute catabolic rate; acriflavine; adenomatosis of colon and rectu...
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
MR Maddox rods; magnetic resistance; magnetic resonance; mandibular reflex; mannose-resistant; may repe...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DCP digestible crude protein
ILS Increase Life Span
ILS Increase of life span
RVI Regulatory volume increase
CA2+ caused an increase in
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • natural light
    ÀÚ¿¬ ±¤
    ¾î¶² ±â°£ÀÇ Æò±ÕÀ» ÃëÇßÀ» ¶§¿¡ ±× Áøµ¿ ºÐÆ÷°¡ ¾î´À ¹æÇâÀ̳ª ÇÑ°á °°Àº ºû. ºûÀº ÀüÀÚ±âÆÄÀ̰í Àü±âÀå ¶Ç´Â ÀÚ±âÀåÀÌ ºûÀÇ ÁøÇà ¹æÇâ¿¡ ´ëÇØ ¼öÁ÷ÀÎ ¹æÇâÀ¸·Î Áøµ¿Çϸç ÀüÆÄÇØ ³ª¾Æ°¡´Â °ÍÀ¸·Î »ý°¢µÈ´Ù. Ư¼öÇÑ Á¶°Ç ¾Æ·¡¿¡¼­´Â Àü±âÀå ¶Ç´Â ÀÚ±âÀåÀÇ Áøµ¿ ¹æÇâÀÌ ÇÑÂÊÀ¸·Î ½ò¸° ºûÀ» ¸¸µé ¼ö Àִµ¥, ÀÌ ºûÀ» Æí±¤À̶ó Çϰí, ±×·¸Áö ¾ÊÀº ºûÀ» ÀÚ¿¬ ±¤À̶ó ÇÑ´Ù. Àüµî ºûÀ̳ª ±âü¿¡¼­ ³ª¿À´Â ºûÀº ÀϹÝÀûÀ¸·Î ÀÚ¿¬ ±¤ÀÌ´Ù.
  • natural moistening factor
    ÀÚ¿¬ º¸½À ÀÎÀÚ
  • natural parthenogenesis
    ÀÚ¿¬ ó³à »ý½Ä, ÀÚ¿¬ ´Ü¼º »ý½Ä
  • natural polishing or abrasive material
    õ¿¬ ¿¬¸¶ ¿ø·á
  • natural product

    natural purification (ÀÚÁ¤ ÀÛ¿ë

    µ¿ÀǾî=self-
  • natural radiation
    ÀÚ¿¬ ¹æ»ç¼±
  • natural resin
    õ¿¬ ·¹Áø
  • natural selection
    ÀÚ¿¬ ¼±ÅÃ, ÀÚ¿¬ µµÅÂ
  • natural sleep
    ÀÚ¿¬ ¼ö¸é
  • natural ventilation
    ÀÚ¿¬ ȯ±â
  • absorptace rate
    Èí¼öÀ²
    ÀÎü¿¡ Á¶»çµÇ´Â ¹æ»ç¼±¿¡ ´ëÇØ ÀÎü¿¡ Èí¼öµÇ´Â ¹æ»ç¼± ¿¡³ÊÁöÀÇ ºñÀ².
  • absorption rate
    Èí¼öÀ²
    ÀÏÁ¤ ½Ã°£¿¡ »¡¾ÆµéÀÌ´Â ¼Óµµ¸¦ ³ªÅ¸³»´Â À².
  • adjusted death rate
    Á¶Á¤ »ç¸Á·ü
  • attack rate
    ¹ßº´·ü, ÀÌȯÀ²
  • basal metabolic rate
    ±âÃÊ ´ë»çÀ²
    ½Ä»ç ÈÄ ÀÏÁ¤ ½Ã°£ÀÌ Áö³ª°í ³ª¼­ÀÇ ¾ÈÁ¤ »óÅ¿¡¼­ÀÇ »ê¼Ò ¼Òºñ ¼Óµµ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
natural dyes Dye's obtained from animals or plants; examples include carmine, obtained from cochineal in the dried female insect Dactylopius cacti of Central America, and haematoxylin, extracted from the bark of the logwood tree Haematoxylon campechianum in the Caribbean area.
(05 Mar 2000)
natural focus of infection An ecosystem in which an infectious agent normally persists in nature; e.g., yellow fever virus in a jungle monkey-Haemagogus mosquito ecosystem.
(05 Mar 2000)
natural haemolysin Haemolysin occurring in the plasma of an animal of one species, e.g., a dog, which fixes complement with the red blood cells of some other species, e.g., a rabbit, thereby causing haemolysis of the cells of the rabbit, although the dog was not previously exposed to antigenic stimulation with such cells.
(05 Mar 2000)
natural history A former branch of knowledge embracing the study, description, and classification of natural objects (as animals, plants, and minerals) and thus including the modern sciences of zoology, botany, and mineralogy insofar as they existed at that time. In the 17th, 18th, and 19th centuries it was much used for the generalised pursuit of certain areas of science. (webster, 3d ed; from dr. James h. Cassedy, nlm history of medicine division)
(12 Dec 1998)
natural immunity This includes local barriers to infection such as skin, stomach acid, mucous, the cough reflex, enzymes in tears and saliva and skin oils.
(27 Sep 1997)
natural killer cell <haematology, immunology> A certain type of white blood cell that attacks tumour cells and infected body cells by binding to a tumour cell and releasing lethal chemicals. Natural killer cells are thought to play a key role in cancer prevention by killing abnormal cells before they multiply and grow.
(16 Dec 1997)
natural killer cells Large granular lymphocytes which do not express markers of either T or B-cell lineage. These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. NK cells can also use perforin to kill cells in the absence of antibody. Killing may occur without previous sensitization.
Synonym: NK cells.
(05 Mar 2000)
natural killer cell stimulating factor <cytokine> A 75 kD heterodimeric cytokine composed of disulfide-bonded 40 kD and 35 kD subunits that was originally identified by its ability to induce cytotoxic effector cells in synergy with less than optimal concentrations of interleukin-2.
It is released by macrophages in response to infection and promotes the activation of cell-mediated immunity. Specifically, IL-12 triggers the maturation of Thl CD4 cells, specific cytotoxic T-lymphocyte responses and an increase in the activity of NK cells and consequently, it is the initiator of cell-mediated immunity.
It enhances the lytic activity of NK cells, induces interferon production, stimulates the proliferation of activated T-cells and NK cells. Is secreted by human B lymphoblastoid cells (NC 37). May play a role in controlling immunoglobulin isotype selection as it also inhibits IgE synthesis (even in the presence of anti-IFN monoclonal antibody) and as a growth factor for activated CD4+ and CD8+ T-cells independently of interleukin-2, and for CD56+ NK cells but not resting peripheral blood mononuclear cells or resting or activated tonsillar B-cells.
It is likely that interleukin 12 has a major role in protective immunity against viruses and is under study as an immunotherapy in HIV infection.
Formerly referred to as cytotoxic lymphocyte maturation factor.
Acronym: IL-12
(12 Dec 1998)
natural language processing Computer processing of a language with rules that reflect and describe current usage rather than prescribed usage.
(12 Dec 1998)
natural mutation A mutation which occurs by itself without first being affected by a mutagen, for example during the process of DNA replication. Spontaneous mutations arise at a remarkably constant rate. The rate that spontaneous mutations arise has been used as an evolutionary clock to estimate how closely related two (or more) separate species are to each other.
(09 Oct 1997)
natural passive immunity Immunity conferred by the mother on the foetus or newborn.
(14 Nov 1997)
natural pigment A naturally occurring coloured compound; absorbs light in the visible range of the electromagnetic spectrum.
Compare: structural colour.
Synonym: biochrome.
(05 Mar 2000)
natural products Naturally occurring compounds that are end products of secondary metabolism; often, they are unique compounds for particular organisms or classes of organisms.
(05 Mar 2000)
natural selection The hypothesis that genotype environment interactions occurring at the phenotypic level lead to differential reproductive success of individuals and hence to modification of the gene pool of a population.
(18 Nov 1997)
immunity, natural The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from non-specific mechanisms such as genetic endowment, naturally occurring antiviral and bactericidal substances, phagocytosis, and constitutional factors such as body temperature, oxygen tension, and age.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • natural gas
    õ¿¬°¡½º
  • natural generative phonology
    (¾ð)ÀÚ¿¬»ý¼º À½¿î·Ð
  • natural guardian
    (¹ý)Ç÷¿¬ ÈİßÀÎ
  • natural historian
    ¹Ú¹°ÇÐÀÚ;¹Ú¹°ÁöÀúÀÚ
  • natural history
    ¹Ú¹°ÇÐ;(ºñÀü¹®ÀÎÀÇ)¹Ú¹°¿¬±¸;¹Ú¹°Áö;¹ß´Þ»ç;¹ß´Þ°æ·Î;¿¬Çõ(»ç);°èº¸
  • natural langugage
    Àΰø¾ð¾î;±â°è¾ð¾î¿¡ ´ëÇÏ¿©)ÀÚ¿¬¾ð¾î
  • natural law
    ÀÚ¿¬ÀÇ À̹ý;ÀÚ¿¬À²(¹ýÄ¢);õ¸®;ÀÚ¿¬¹ý )
  • natural life
    õ¼ö;õ¸í;¼ö¸í
  • natural logarithm
    (¼ö)ÀÚ¿¬´ë¼ö(cf.COMMON LOGARITHM)
  • natural magnet
    õ¿¬ÀÚ¼®(lodestone)
  • natural number
    (¼ö)ÀÚ¿¬¼ö(¾çÀÇ Á¤¼ö)
  • natural order
    ÀÚ¿¬À²;ÀÚ¿¬°èÀÇ Áú¼­;(»ý);°ú;(¿µ)NATURAL SYSTEM
  • natural person
    (¹ý)ÀÚ¿¬ÀÎ(¹ýÀο¡ ´ëÇÏ¿©)
  • natural philosophy
    ÀÚ¿¬Ã¶ÇÐ(Áö±ÝÀÇ natural science ƯÈ÷ physics)
  • natural religion
    ÀÚ¿¬Á¾±³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á